Viewing nowClopidogrel Tablets (Clopidogrel Bisulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 200608038 · Notified 2006.11.24 · Insurance code 641602350
Improvement of symptoms of atherosclerosis and acute coronary syndrome, and reduction of thromboembolic risk in atrial fibrillation
This drug is used to improve symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, and peripheral arterial disease. It also helps reduce the risk of cardiovascular complications in patients with acute coronary syndrome, specifically those with unstable angina or non-ST elevation myocardial infarction, who are receiving medical treatment, coronary intervention, or coronary artery bypass surgery. Additionally, it is used to decrease the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not appropriate. Overall, this medication effectively improves the risks and symptoms of cardiovascular and cerebrovascular diseases.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the day this medicine is started with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.
This drug helps prevent platelets from aggregating, allowing blood to flow more freely. Caution is warranted for individuals with genetically reduced function of a specific enzyme, CYP2C19, as this may decrease the drug's effectiveness. Moreover, co-administration of this drug with medications that activate the CYP2C19 enzyme may increase the risk of bleeding, thus concurrent use should be avoided. Patients with a known allergy to this drug or its components, patients with bleeding disorders, severely damaged liver function, nursing mothers, and individuals with certain genetic conditions should not take this medication. Patients at high risk for bleeding or those scheduled for surgery should consult with their physician about medication management, particularly when taking other antiplatelet agents or anticoagulant medications, as additional caution is required. This medication may cause bleeding, thus it is important to immediately inform healthcare personnel of any signs or symptoms of bleeding that occur. It is necessary to regularly monitor for any bleeding or blood abnormalities through blood tests or other required examinations. This drug may result in various side effects such as gastrointestinal disturbances, headache, dizziness, rash, fatigue, and if symptoms are severe or persistent, consultation with a doctor is necessary. Particularly, bleeding-related side effects are the most common; therefore, it is crucial to notify healthcare personnel immediately if symptoms such as nosebleeds, gum bleeding, bruising, hematuria, or coughing up blood occur. If pregnant or breastfeeding, it is important to discuss any potential effects of this drug on the fetus or infant with a physician, and whether to continue breastfeeding while taking the medication should be carefully considered. Children and the elderly may have different safety and effectiveness profiles for this drug; special caution is recommended, especially for the elderly, as they may have a higher risk of bleeding and should take the medication as directed by their physician. Overdosing on this drug can increase bleeding risk, so it is essential to adhere strictly to the prescribed dosage. In case of overdose, it is imperative to go to the hospital immediately. This medication should be kept out of the reach of children and it is advisable to avoid transferring it to other containers. Finally, when starting new medications or planning surgeries while taking this drug, it is essential to inform healthcare personnel about its use.
Hemorrhage, gastrointestinal hemorrhage, bleeding requiring hospitalization, petechiae, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major hemorrhage, life-threatening hemorrhage, fatal hemorrhage, hemorrhagic stroke, mild hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, weakness, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory impairment, neuralgia, sensory disturbance, vertigo, constipation, vomiting, elevated liver enzymes, gout, hyperuricemia, arthritis, arthrosis, anxiety, insomnia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer hemorrhage, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria syndrome, hemoptysis, retroperitoneal hemorrhage, surgical incision hemorrhage, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, stomatitis, hepatitis, acute liver failure, petechial rash, erythematous skin rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, arthralgia, myalgia, glomerular disease, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness for a longer period.
Pink round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.